Nicox SA announced that it has entered into an
exclusive agreement with Immco Diagnostics, Inc., a provider
of autoimmune diagnostic products and services,
to promote a proprietary laboratory test for the early
detection and diagnosis of Sjögren syndrome, according
to a Nicox news release.
Under the terms of the ag…
Surgeon-controlled intracameral illumination can be
used for challenging cataract surgery combined with
23-gauge vitrectomy in eyes with a poor red reflex,
according to a study in the Journal of Cataract and
Refractive Surgery.sup1/sup
The interventio…
Patients with the Kamra inlay (AcuFocus, Inc.; not
approved in the United States) achieved J2 uncorrected
near visual acuity and 20/25 for both uncorrected
intermediate and distance visual acuities 5 years postoperatively,
according to a company news r…
Scientists at The University of Nottingham, United
Kingdom, have discovered a previously undetected
layer in the cornea that could help surgeons to dramatically
improve outcomes for patients undergoing corneal
grafts and transplants, according to a new…
Perrigo Company has signed a definitive agreement
to acquire the ophthalmic sterile ointment and solution
product portfolio from Fera Pharmaceuticals, LLC, and
its affiliates, according to a Perrigo news release.
Terms of the transaction include an up…
Cataracts caused by ocular toxocariasis have a
granuloma-like opacity primarily in the posterior subcapsular
level, according to a study in the Journal of
Cataract and Refractive Surgery.sup1/sup
The investigators based the clinical diagnosis of ocula…
OptiMedica Corporation announced that it has
been awarded a tender for five Catalys Precision Laser
Systems for use in a French multicenter randomized
clinical study.
The study, which is sponsored by Centre Hospitalier
Universitaire de Bordeaux, Franc…
Myopia and astigmatism are most prevalent in the
Chinese population, and hyperopia is most common
in the Hispanic population, according to a study in the
emAmerican Journal of Ophthalmology/em.sup1/sup
The study included participants in the Multi-Ethn…
Pretreatment with a femtosecond laser significantly
reduced effective phacoemulsification time (EPT),
according to a study in emOphthalmology/em.sup1/sup
The prospective, interventional, consecutive casecontrolled
study included 201 eyes that underwen…
In a blockbuster deal that may reshape the eye care
landscape, Canadian drugmaker Valeant Pharmaceuticals
International Inc. announced it will acquire Bausch + Lomb
for $8.7 billion in cash.
Under the terms of the agreement, Valeant will pay
about $4….
Enrollment has begun in the confirmatory phase 3
clinical trial of BromSite (ISV-303; InSite Vision Inc.) for
the reduction of inflammation and pain after cataract
surgery.
ISV-303 combines a low dose (0.075%) of the nonsteroidal
antiinflammatory drug bromfenac with
InSite’s DuraSite drug delivery technology. This…
The Trulign Toric PCIOL (Bausch + Lomb), the first
toric IOL that provides astigmatic correction and
improved uncorrected near, intermediate, and distance
vision, has received FDA approval.
The FDA-approved indication of the Trulign is for
“primary implantation in the capsular bag of the eye
for the visual correct…
The causes of laser-related programming errors in
refractive surgery are likely avoidable if preventive
measures such as strict adherence to patients’ verification
protocol or rigorous rechecking of treatment
parameters are implemented, according to a study in
the emJournal of Refractive Surgery/em.sup1/sup
In a m…
Corneal endothelial cell loss and a transient
increase in central corneal thickness (CCT) were
greater after cataract surgery in eyes with pseudoexfoliation
(PXF) than in eyes without PXF, according
to a study in the Journal of Cataract and Refractive
…
Corneal collagen cross-linking (CXL) stabilized the
progression of ectatic disease 4 years postoperatively
in all age groups and improved the functional and
morphological parameters in select groups, with the
best results in patients between 18 and 39 …
Aaren Scientific has been granted approval by the
FDA to sell the Aero Injection System for use with the
company’s EC-3 and EC-3 PAL aspheric three-piece
hydrophobic acrylic IOL, according to a company
news release.
The Aero Injection System is composed of the
R28 Model IOL Delivery System Injector and the Aero
Z…
In a blockbuster deal that may reshape the eye care
landscape, Canadian drugmaker Valeant Pharmaceuticals
International Inc. announced it will acquire Bausch + Lomb
for $8.7 billion in cash.
Under the terms of the agreement, Valeant will pay
about $4….
Marguerite McDonald, MD, was recently recognized
for her accomplishments in ophthalmology by CNN.
Her career and landmark contributions were profiled
in the Life’s Work series, which features “innovators
and pioneers who are making a difference in the
world of medicine.”
Specific milestones highlighted by CNN …
Pretreatment with a femtosecond laser significantly
reduced effective phacoemulsification time (EPT),
according to a study in emOphthalmology/em.sup1/sup
The prospective, interventional, consecutive casecontrolled
study included 201 eyes that underwen…
Enrollment has begun in the confirmatory phase 3
clinical trial of BromSite (ISV-303; InSite Vision Inc.) for
the reduction of inflammation and pain after cataract
surgery.
ISV-303 combines a low dose (0.075%) of the nonsteroidal
antiinflammatory drug bromfenac with
InSite’s DuraSite drug delivery technology. This…